• Tech
• Gadgets
• Mobile
• Enterprise
• CrunchBase
• More
  • Beta Invites
  • Elevator Pitches
  • Gillmor Gang
  • Podcasts
  • TechCrunch50
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Alimera Sciences

edit

Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.

Milestones

edit

• 
  Alimera Sciences received $5M in Series C funding. (10/09)
  Posted 10/21/09 at 6:23pm
• 
  Alimera Sciences received $30M in Series C funding. (3/08)
  Posted 6/19/09 at 4:59am
• 
  Alimera Sciences added Susan Caballa as Sr. Vice President, Regulatory & Medical Affairs.
  Posted 6/19/09 at 4:59am
• 
  Alimera Sciences added Dan Myers as President and CEO.
  Posted 6/19/09 at 4:59am
• 
  Alimera Sciences added Rick Eiswirth as CFO.
  Posted 6/19/09 at 4:59am
• 
  Alimera Sciences added Ken Greene as Sr. Vice President & CSO .
  Posted 6/19/09 at 4:59am

Videos

Screenshots

edit

Above: Homepage
Uploaded: 6/19/09

Products

edit

Iluvien

edit

Sources

1. Alimera Sciences Closes $30 Million In Series C Financing, Increasing Stake In Medidur™ FA (alimerasciences.com) [edit]
2. Alimera Sciences, Inc.: Series C $5M (onbiovc.com) [edit]